Kitschen A, Asegu L, Sauerland D
BMC Pediatr. 2025; 25(1):73.
PMID: 39881240
PMC: 11776138.
DOI: 10.1186/s12887-024-05384-9.
Khalik H, Nijjar M, Soeder J, Lameire D, Johal H
HSS J. 2025; 21(1):93-101.
PMID: 39846060
PMC: 11748386.
DOI: 10.1177/15563316231204040.
Bolous Y, Koto P, Sapp J, Gray C, Lee D, Berbenetz N
CJC Open. 2024; 6(11):1372-1378.
PMID: 39582704
PMC: 11583884.
DOI: 10.1016/j.cjco.2024.07.016.
Putri S, Ciminata G, Lewsey J, Jani B, McMeekin N, Geue C
BMC Health Serv Res. 2024; 24(1):1060.
PMID: 39272116
PMC: 11396645.
DOI: 10.1186/s12913-024-11559-y.
Fatoye F, Gebrye T, Nherera L, Trueman P
J Mark Access Health Policy. 2024; 12(3):216-223.
PMID: 39193540
PMC: 11348208.
DOI: 10.3390/jmahp12030018.
Considerations Around the Inclusion of Children and Young People's Time in Economic Evaluation: Findings from an International Delphi Study.
Morgan C, Donaldson C, Lancsar E, Petrou S, Andronis L
Pharmacoeconomics. 2024; 42(11):1267-1277.
PMID: 39153138
PMC: 11499441.
DOI: 10.1007/s40273-024-01411-w.
Cost-Effectiveness of an Intensive Upper Limb Rehabilitation Therapy for Children With Unilateral Cerebral Palsy: An Economic Evaluation of a Randomized Controlled Trial.
David M, Higashi H
J Health Econ Outcomes Res. 2024; 11(1):103-111.
PMID: 38779334
PMC: 11110886.
DOI: 10.36469/001c.94460.
The economic impact of anastomotic leakage after colorectal surgery: a systematic review.
Nijssen D, Wienholts K, Postma M, Tuynman J, Bemelman W, Lameris W
Tech Coloproctol. 2024; 28(1):55.
PMID: 38769231
PMC: 11106156.
DOI: 10.1007/s10151-024-02932-4.
An overview of the perspectives used in health economic evaluations.
Sittimart M, Rattanavipapong W, Mirelman A, Hung T, Dabak S, Downey L
Cost Eff Resour Alloc. 2024; 22(1):41.
PMID: 38741138
PMC: 11092188.
DOI: 10.1186/s12962-024-00552-1.
The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries.
Mokri H, van Baal P, Rutten-van Molken M
Eur J Health Econ. 2024; 26(1):71-85.
PMID: 38700736
PMC: 11743354.
DOI: 10.1007/s10198-024-01690-2.
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus.
Pitsillidou O, Petrou P, Postma M
Pharmacoecon Open. 2024; 8(3):471-480.
PMID: 38575797
PMC: 11058738.
DOI: 10.1007/s41669-024-00482-x.
Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care - Protocol for a health economic evaluation alongside a randomized controlled trial.
Eckhardt H, Quentin W, Silzle J, Busse R, Rombey T
BMC Geriatr. 2024; 24(1):231.
PMID: 38448804
PMC: 10916129.
DOI: 10.1186/s12877-024-04833-5.
On spillovers in economic evaluations: definition, mapping review and research agenda.
Mendoza-Jimenez M, van Exel J, Brouwer W
Eur J Health Econ. 2024; 25(7):1239-1260.
PMID: 38261132
PMC: 11377364.
DOI: 10.1007/s10198-023-01658-8.
Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial.
Arfuch V, Aguilar Martin C, Berenguera A, Caballol Angelats R, Goncalves A, Carrasco-Querol N
J Rehabil Med. 2023; 55:jrm12361.
PMID: 38111994
PMC: 10753594.
DOI: 10.2340/jrm.v55.12361.
Preventing chronic malnutrition in children under 2 years in rural Angola (MuCCUA trial): protocol for the economic evaluation of a three-arm community cluster randomised controlled trial.
Martin-Canavate R, Custodio E, Trigo E, Romay-Barja M, Herrador Z, Aguado I
BMJ Open. 2023; 13(12):e073349.
PMID: 38110392
DOI: 10.1136/bmjopen-2023-073349.
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?.
Cubi-Molla P, Mott D, Henderson N, Zamora B, Grobler M, Garau M
Cost Eff Resour Alloc. 2023; 21(1):96.
PMID: 38102674
PMC: 10722785.
DOI: 10.1186/s12962-023-00500-5.
One-year direct and indirect costs of ischaemic stroke in China.
Lv W, Wang A, Wang Q, Wang R, Xu Q, Wu S
Stroke Vasc Neurol. 2023; 9(4):380-389.
PMID: 37788911
PMC: 11420908.
DOI: 10.1136/svn-2023-002296.
Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
Ramsay L, Richardson M, Miranda R, Hassan M, Brode S, Rea E
PLoS One. 2023; 18(8):e0290710.
PMID: 37624844
PMC: 10456154.
DOI: 10.1371/journal.pone.0290710.
Expert opinion on a consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies: qualitative interviews.
Schnitzler L, Paulus A, Evers S, Roberts T, Jackson L
Int J Technol Assess Health Care. 2023; 39(1):e33.
PMID: 37293924
PMC: 11574535.
DOI: 10.1017/S0266462323000181.
Cognitive-behavioral rehabilitation in patients with cardiovascular diseases: a randomized controlled trial (CBR-CARDIO, DRKS00029295).
Bethge M, Thome-Soos F, Raso L, Weier L, Benninghoven D
BMC Cardiovasc Disord. 2023; 23(1):252.
PMID: 37189029
PMC: 10186766.
DOI: 10.1186/s12872-023-03272-1.
